Extended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients: a systematic review and meta-analysis of randomized controlled trials

Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients

(2016) Alexander T. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE

(2016) Alex Spyropoulos et al.   THROMBOSIS AND HAEMOSTASIS

Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients

(2015) Serge Korjian et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Venous Thromboembolism in Elderly High-Risk Medical Patients

(2013) Russell D. Hull et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients

(2013) Alexander T. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population

(2013) Charles E. Mahan et al.   THROMBOSIS RESEARCH

The global burden of unsafe medical care: analytic modelling of observational studies

(2013) Ashish K Jha et al.   BMJ Quality & Safety

Prevention of VTE in Orthopedic Surgery Patients

(2012) Yngve Falck-Ytter et al.   CHEST

Prevention of VTE in Nonsurgical Patients

(2012) Susan R. Kahn et al.   CHEST

Predictive and Associative Models to Identify Hospitalized Medical Patients at Risk for VTE

(2011) Alex C. Spyropoulos et al.   CHEST

Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol

(2011) Alexander Thomas Cohen et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients

(2011) Samuel Z. Goldhaber et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE